About
Cellusion Inc is a clinical-stage biotech company developing iPSC-derived corneal endothelial cell therapies to address global shortages and complications associated with traditional corneal transplants, using cell injection treatments that reduce patient burden and surgical complexity.
Explore Cellusion Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.